Immunovant, Inc. IMVT Switzerland — Net operating loss carry forwards

Other geography segments

Similar metrics at other companies

MHKLuxembourg — Net operating loss carryforwards in various foreign jurisdictions

$1.23B+12.9%

GRMNNon Switzerland — Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

$153.35M+42.1%

PLDOther Countries — Operating Loss Carryforwards

$34.16M+5.4%

PLTRNon-US — Net operating loss carryforwards

$1.8B+100%

ETForeign — Operating Loss Carryforwards

$425M—

TEXAll other — Operating loss carryforwards

$71M+44.9%

Questions, answered.

What is Immunovant, Inc.'s switzerland — net operating loss carry forwards?

Immunovant, Inc. (IMVT) reported switzerland — net operating loss carry forwards of $279M in Q1 2026.

How has Immunovant, Inc.'s switzerland — net operating loss carry forwards changed year-over-year?

Immunovant, Inc.'s switzerland — net operating loss carry forwards decreased by 74.5% year-over-year, from $1.09B to $279M.

What does switzerland — net operating loss carry forwards mean?

This metric quantifies the accumulated tax losses from the Switzerland segment that can be applied to offset future taxable income in that jurisdiction. It serves as a potential future tax asset that may reduce the company's effective tax rate once the segment reaches profitability. Investors track this to evaluate the long-term tax efficiency and deferred tax benefits associated with the company's international operations.